Literature DB >> 8083982

Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.

B Rombaut1, B Verheyden, K Andries, A Boeyé.   

Abstract

Heating the Sabin strains of poliovirus at 42 to 45 degrees C caused inactivation, loss of native antigen, and release of the viral RNA (vRNA). The loss of virion infectivity exceeded the loss of vRNA infectivity (as measured by transfection) by roughly 2 log10. Pirodavir inhibited the loss of native antigen and RNA release and reduced the loss of virion infectivity to the same level as the loss of vRNA infectivity. Thermoinactivation thus involves an RNA and a protein component, and pirodavir protected only against the latter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083982      PMCID: PMC237065     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Foot and mouth disease virus. II. Endoribonuclease activity within purified virions.

Authors:  C D Denoya; E A Scodeller; C Vasquez; J L La Torre
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

2.  Ribonuclease activities associated with purified foot and mouth disease virus.

Authors:  C D Denoya; E A Scodeller; C Vasquez; J L La Torre
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  The interaction of tritium-labelled mengo virus RNA and L cells: the effects of DMSO and DEAE-dextran.

Authors:  D R Tovell; J S Colter
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

4.  Differences between the thermal inactivation of picornaviruses at "high" and "low" temperatures.

Authors:  N J Dimmock
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

5.  Kinetic studies on the thermal degradation of purified poliovirus.

Authors:  Y Hinuma; S Katagiri; M Fukuda; K Fukushi; Y Watanabe
Journal:  Biken J       Date:  1965-09

6.  Hybridoma antibodies to poliovirus N and H antigen.

Authors:  P Brioen; R J Sijens; R Vrijsen; B Rombaut; A A Thomas; A Jackers; A Boeyé
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  A simple quantitative protein A micro-immunoprecipitation method; assay of antibodies to the N and H antigens of poliovirus.

Authors:  R Vrijsen; B Rombaut; A Boeyé
Journal:  J Immunol Methods       Date:  1983-04-29       Impact factor: 2.303

8.  Structural subunits of poliovirus particles by electron microscopy.

Authors:  M Boublik; R Drzeniek
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

9.  Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.

Authors:  H Ishitsuka; Y T Ninomiya; C Ohsawa; M Fujiu; Y Suhara
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  4',6-Dichloroflavan (BW683C), a new anti-rhinovirus compound.

Authors:  D J Bauer; J W Selway; J F Batchelor; M Tisdale; I C Caldwell; D A Young
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

View more
  5 in total

1.  Quantitative PCR for determining the infectivity of bacteriophage MS2 upon inactivation by heat, UV-B radiation, and singlet oxygen: advantages and limitations of an enzymatic treatment to reduce false-positive results.

Authors:  Brian M Pecson; Luisa Valério Martin; Tamar Kohn
Journal:  Appl Environ Microbiol       Date:  2009-07-10       Impact factor: 4.792

2.  Infectivity of RNA from inactivated poliovirus.

Authors:  Suphachai Nuanualsuwan; Dean O Cliver
Journal:  Appl Environ Microbiol       Date:  2003-03       Impact factor: 4.792

3.  Viruses contained in droplets applied on warmed surface are rapidly inactivated.

Authors:  Swan Firquet; Sophie Beaujard; Pierre-Emmanuel Lobert; Famara Sané; Delphine Caloone; Daniel Izard; Didier Hober
Journal:  Microbes Environ       Date:  2014-12-03       Impact factor: 2.912

4.  Cross-Resistance of UV- or Chlorine Dioxide-Resistant Echovirus 11 to Other Disinfectants.

Authors:  Qingxia Zhong; Anna Carratalà; Rachele Ossola; Virginie Bachmann; Tamar Kohn
Journal:  Front Microbiol       Date:  2017-10-04       Impact factor: 5.640

5.  Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.

Authors:  Abhay Kotecha; Fuquan Zhang; Nicholas Juleff; Terry Jackson; Eva Perez; Dave Stuart; Elizabeth Fry; Bryan Charleston; Julian Seago
Journal:  J Gen Virol       Date:  2016-03-22       Impact factor: 3.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.